Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 23% ± 6% | |
epithelial cell | 5 studies | 32% ± 12% | |
basal cell | 4 studies | 22% ± 7% | |
ciliated cell | 3 studies | 22% ± 3% | |
dendritic cell | 3 studies | 20% ± 2% | |
plasmacytoid dendritic cell | 3 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2278.62 | 2642 / 2642 | 100% | 33.93 | 705 / 705 |
esophagus | 100% | 2553.14 | 1445 / 1445 | 100% | 32.33 | 183 / 183 |
lung | 100% | 1906.57 | 578 / 578 | 100% | 26.01 | 1155 / 1155 |
prostate | 100% | 2233.04 | 245 / 245 | 100% | 24.84 | 502 / 502 |
stomach | 100% | 1883.81 | 359 / 359 | 100% | 28.36 | 286 / 286 |
uterus | 100% | 2460.55 | 170 / 170 | 100% | 28.25 | 459 / 459 |
breast | 100% | 2140.03 | 459 / 459 | 100% | 24.78 | 1117 / 1118 |
thymus | 100% | 1987.83 | 653 / 653 | 100% | 22.01 | 604 / 605 |
intestine | 100% | 2360.33 | 966 / 966 | 100% | 26.38 | 526 / 527 |
bladder | 100% | 2669.57 | 21 / 21 | 100% | 27.01 | 503 / 504 |
ovary | 100% | 2557.10 | 180 / 180 | 100% | 33.98 | 429 / 430 |
skin | 100% | 2491.60 | 1808 / 1809 | 100% | 32.57 | 471 / 472 |
kidney | 100% | 2259.69 | 89 / 89 | 100% | 18.95 | 897 / 901 |
pancreas | 100% | 1262.57 | 327 / 328 | 99% | 19.37 | 177 / 178 |
liver | 100% | 1326.89 | 226 / 226 | 98% | 12.81 | 396 / 406 |
adrenal gland | 100% | 2282.85 | 258 / 258 | 97% | 15.38 | 224 / 230 |
adipose | 100% | 2118.91 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2029.65 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.69 | 29 / 29 |
spleen | 100% | 1758.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.94 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.43 | 1 / 1 |
muscle | 100% | 1528.40 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1547.90 | 846 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 18.79 | 77 / 80 |
peripheral blood | 77% | 1329.75 | 717 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006309 | Biological process | apoptotic DNA fragmentation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0061077 | Biological process | chaperone-mediated protein folding |
GO_0032076 | Biological process | negative regulation of deoxyribonuclease activity |
GO_0070242 | Biological process | thymocyte apoptotic process |
GO_1900118 | Biological process | negative regulation of execution phase of apoptosis |
GO_1902511 | Biological process | negative regulation of apoptotic DNA fragmentation |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005886 | Cellular component | plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0044183 | Molecular function | protein folding chaperone |
GO_0060703 | Molecular function | deoxyribonuclease inhibitor activity |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0005515 | Molecular function | protein binding |
Gene name | DFFA |
Protein name | DNA fragmentation factor subunit alpha (DNA fragmentation factor 45 kDa subunit) (DFF-45) (Inhibitor of CAD) (ICAD) DNA fragmentation factor subunit alpha |
Synonyms | DFF45 H13 DFF1 |
Description | FUNCTION: Inhibitor of the caspase-activated DNase (DFF40). |
Accessions | ENST00000476658.5 ENST00000377036.2 [O00273-2] K7ERT1 ENST00000377038.8 [O00273-1] O00273 |